The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

Not Applicable

Completed

• Conditions: HIV Infections; Mycobacterium Avium-intracellular Infection

• Registration Number: NCT00002336
• Lead Sponsor: Abbott

Brief Summary

To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts \<= 100 cells/mm3.

Detailed Description

Not available

Study Timeline

• Study Start: 1992-11
• Primary Completion: 1994-11
• Study Completion: 1994-11
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Status Verified: 2009-02
• Last Update Submitted: 2015-01-15
• Last Update Posted: 2015-01-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (22)

Univ of Arizona / Health Science Ctr; 🇺🇸 Tucson, Arizona, United States

California Med Research Group; 🇺🇸 Fresno, California, United States

HIV Research Group; 🇺🇸 San Diego, California, United States

Saint Francis Mem Hosp; 🇺🇸 San Francisco, California, United States

Kaiser Permanente Med Ctr; 🇺🇸 San Francisco, California, United States

Santa Clara Valley Med Ctr; 🇺🇸 San Jose, California, United States

TheraFirst Med Ctrs Inc; 🇺🇸 Fort Lauderdale, Florida, United States

Dr Nelson Zide; 🇺🇸 Hollywood, Florida, United States

Infectious Disease Research Institute Inc; 🇺🇸 Tampa, Florida, United States

Indiana Univ Hosp; 🇺🇸 Indianapolis, Indiana, United States

Scroll for more (12 remaining)